Antibe Announces Appointment of Receiver
24 Aprile 2024 - 5:15PM
Business Wire
Antibe Therapeutics Inc. (“Antibe” or the
“Company”) (TSX: ATE) announced that the Company’s request
for an extension of its previously announced stay of proceedings
under the Companies’ Creditors Arrangement Act (the “CCAA”)
was heard before the Ontario Superior Court of Justice (Commercial
List) (the “Court”) on April 18, 2024 and the decision was
reserved.
On April 22, 2024, the Court issued its decision terminating
CCAA proceedings and appointing FTI Consulting Canada Inc. as
receiver of Antibe.
The Company also announced that Roderick Flower, Robert Hoffman,
Dan Legault, Walt Macnee and Yung Wu have resigned from Antibe’s
Board of Directors. In addition, the Company today received
notification from the TSX that it will be delisting Antibe’s common
shares from the TSX effective as of May 24, 2024.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240424042966/en/
Antibe Therapeutics Inc. Christina Cameron VP Investor Relations
+1 416-577-1443 christina@antibethera.com
Grafico Azioni Antibe Therapeutics (TSX:ATE)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Antibe Therapeutics (TSX:ATE)
Storico
Da Mag 2023 a Mag 2024
